Gloger S

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (1)

Title : The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors - Grossberg_2013_CNS.Drugs_27_469
Author(s) : Grossberg GT , Manes F , Allegri RF , Gutierrez-Robledo LM , Gloger S , Xie L , Jia XD , Pejovic V , Miller ML , Perhach JL , Graham SM
Ref : CNS Drugs , 27 :469 , 2013
Abstract : Grossberg_2013_CNS.Drugs_27_469
ESTHER : Grossberg_2013_CNS.Drugs_27_469
PubMedSearch : Grossberg_2013_CNS.Drugs_27_469
PubMedID: 23733403